$48.44
-4.86-9.12%
Last update: Dec 16, 9:30 AM
Comments
Loading...
Nektar Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:NKTR | Benzinga
Nektar Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 11
EPS Estimate
$-3.050
Quarterly Revenue Estimate
$10.08M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$62.60M
Analyze the earnings history of Nektar Therapeutics using advanced sorting and filters.
Nektar Therapeutics (NKTR) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $-1.87 | $-2.81 | 33.5 % |
| Q2 | 2025-08-07 | $-2.95 | $-3.12 | 5.45 % |
| Q1 | 2025-05-08 | $-3.60 | $-2.70 | -33.3 % |
| Q4 | 2025-03-12 | $-2.25 | $-2.85 | 21.1 % |
Nektar Therapeutics (NKTR) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $11.79M | $10.35M | 13.9 % |
| Q2 | 2025-08-07 | $11.18M | $9.96M | 12.2 % |
| Q1 | 2025-05-08 | $10.46M | $15.61M | -33.0 % |
| Q4 | 2025-03-12 | $29.18M | $36.66M | -20.4 % |
FAQ
When is Nektar Therapeutics (NASDAQ:NKTR) reporting earnings?
Nektar Therapeutics (NKTR) is scheduled to report earnings on March 11, 2026. The last reported earnings were for reported on November 6, 2025 for Q3.
What were the latest earnings per share (EPS) for Nektar Therapeutics (NASDAQ:NKTR)?
The Actual EPS was $-1.87, which beat the estimate of $-2.81.
What were Nektar Therapeutics’s (NASDAQ:NKTR) revenues?
The Actual Revenue was $11.8M, which beat the estimate of $10.4M.
Browse earnings estimates, EPS, and revenue on all stocks.
